Multiple Modes of Activation of Latent Human Fibroblast Collagenase: Evidence for the Role of a Cys73 Active-site Zinc Complex in Latency and a "cysteine Switch" Mechanism for Activation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1990 Jan 1

PMID 2153297

Citations 142

Authors

E B Springman

E L Angleton

H Birkedal-Hansen

H E Van Wart

Affiliations

Soon will be listed here.

Abstract

Latent human fibroblast collagenase (HFC) can be activated by a variety of seemingly disparate means. In addition to the well-characterized activation by trypsin and organomercurial compounds, the enzyme can be activated to various extents by surfactants such as sodium dodecyl sulfate, by chaotropic ions such as SCN-, by disulfide compounds such as oxidized glutathione, by sulfhydryl alkylating agents such as N-ethylmaleimide, and by oxidants such as NaOCl. The underlying basis for these activations is the modification, exposure, or proteolytic release of the Cys73 residue from its habitat in the latent enzyme where it is thought to be complexed to the active-site zinc atom. This residue is not accessible for reaction with small molar excesses of dithionitrobenzoate in native, latent HFC. However, on addition of EDTA, this residue becomes fully exposed and is quantitatively labeled. All modes of activation of latent HFC are believed to involve the dissociation of Cys73 from the active-site zinc atom and its replacement by water, with the concomitant exposure of the active site. This is thought to be the primary event that precedes the well-known autolytic cleavages that are observed following the appearance of collagenase activity. The dissociation of Cys73 from the zinc atom in the latent enzyme "switches" the role of the zinc from a noncatalytic to a catalytic one. This "cysteine switch" mechanism of regulation may be applicable to the entire collagenase gene family.

Citing Articles

Dissecting Cytophagalysin: Structural and Biochemical Studies of a Bacterial Pappalysin-Family Metallopeptidase.

Estevan-Morio E, Ramirez-Larrota J, Bushi E, Eckhard U Biomolecules. 2025; 14(12.

PMID: 39766312 PMC: 11674741. DOI: 10.3390/biom14121604.

Influence of dexamethasone-induced matrices on the TM transcriptome.

Soundappan K, Cai J, Yu H, Dhamodaran K, Baidouri H, Vranka J Exp Eye Res. 2024; 248:110069.

PMID: 39233306 PMC: 11531998. DOI: 10.1016/j.exer.2024.110069.

The Expanding Scope of Alpha 1 Antitrypsin Deficiency.

Kueppers F Mayo Clin Proc Innov Qual Outcomes. 2024; 8(1):58-61.

PMID: 38283099 PMC: 10818156. DOI: 10.1016/j.mayocpiqo.2023.12.001.

Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody.

Velasquez M, OSullivan C, Brockett R, Mikels-Vigdal A, Mikaelian I, Smith V Antibodies (Basel). 2023; 12(1).

PMID: 36810514 PMC: 9944116. DOI: 10.3390/antib12010009.

The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer.

He L, Kang Q, Chan K, Zhang Y, Zhong Z, Tan W Front Immunol. 2023; 13:1093990.

PMID: 36776395 PMC: 9910179. DOI: 10.3389/fimmu.2022.1093990.

References

Sorsa T, Suomalainen K, Turto H, Lindy S . Latent human leukocyte collagenase can be activated by gold thioglucose and gold sodium thiomalate, but not by auranofin. Biosci Rep. 1987; 7(12):965-8. DOI: 10.1007/BF01122130. View

Nicholson R, Gesnel M, Matrisian L, Breathnach R . Structure-function relationships in the collagenase family member transin. J Biol Chem. 1988; 263(24):11892-9. View

Muller D, Quantin B, Gesnel M, Abecassis J, Breathnach R . The collagenase gene family in humans consists of at least four members. Biochem J. 1988; 253(1):187-92. PMC: 1149273. DOI: 10.1042/bj2530187. View

Moore W, Taylor R, BHOWN A, Birkedal-Hansen H . Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme. Biochemistry. 1988; 27(18):6751-8. DOI: 10.1021/bi00418a016. View

Mallya S, Van Wart H . Mechanism of inhibition of human neutrophil collagenase by Gold(I) chrysotherapeutic compounds. Interaction at a heavy metal binding site. J Biol Chem. 1989; 264(3):1594-601. View

Stack M, Gray R . Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide. J Biol Chem. 1989; 264(8):4277-81. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Vaes G . The release of collagenase as an inactive proenzyme by bone explants in culture. Biochem J. 1972; 126(2):275-89. PMC: 1178378. DOI: 10.1042/bj1260275. View

Abe S, Nagai Y . Evidence for the presence of a latent form of collagenase in human rheumatoid synovial fluid. J Biochem. 1972; 71(5):919-22. DOI: 10.1093/oxfordjournals.jbchem.a129846. View

10.

Abe S, Shinmei M, Nagai Y . Synovial collagenase and joint diseases: the significancy of latent collagenase with special reference to rheumatoid arthritis. J Biochem. 1973; 73(5):1007-11. DOI: 10.1093/oxfordjournals.jbchem.a130154. View

11.

Stricklin G, Bauer E, Jeffrey J, Eisen A . Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry. 1977; 16(8):1607-15. DOI: 10.1021/bi00627a013. View

12.

Eeckhout Y, Vaes G . Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J. 1977; 166(1):21-31. PMC: 1164952. DOI: 10.1042/bj1660021. View

13.

Riddles P, Blakeley R, ZERNER B . Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid)--a reexamination. Anal Biochem. 1979; 94(1):75-81. DOI: 10.1016/0003-2697(79)90792-9. View

14.

Uitto V, Turto H, Huttunen A, Lindy S, Uitto J . Activation of human leukocyte collagenase by compounds reacting with sulfhydryl groups. Biochim Biophys Acta. 1980; 613(1):168-77. DOI: 10.1016/0005-2744(80)90203-x. View

15.

Merril C, Goldman D, Sedman S, EBERT M . Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science. 1981; 211(4489):1437-8. DOI: 10.1126/science.6162199. View

16.

Murphy G, Bretz U, Baggiolini M, Reynolds J . The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J. 1980; 192(2):517-25. PMC: 1162366. DOI: 10.1042/bj1920517. View

17.

Harrison R, Thomas M, Tack B . Sequence determination of the thiolester site of the fourth component of human complement. Proc Natl Acad Sci U S A. 1981; 78(12):7388-92. PMC: 349272. DOI: 10.1073/pnas.78.12.7388. View

18.

Thomas M, Janatova J, Gray W, Tack B . Third component of human complement: localization of the internal thiolester bond. Proc Natl Acad Sci U S A. 1982; 79(4):1054-8. PMC: 345898. DOI: 10.1073/pnas.79.4.1054. View

19.

Dideberg O, Charlier P, Dive G, Joris B, Frere J, Ghuysen J . Structure of a Zn2+-containing D-alanyl-D-alanine-cleaving carboxypeptidase at 2.5 A resolution. Nature. 1982; 299(5882):469-70. DOI: 10.1038/299469a0. View

20.

Birkedal-Hansen H, Taylor R . Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun. 1982; 107(4):1173-8. DOI: 10.1016/s0006-291x(82)80120-4. View